TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.18, sa.2, ss.62-68, 2009 (ESCI)
Background : The introduction of renin angiotensin system blockers (RASB) might challenge the previous results of immunosuppressive therapies in idiopathic membranous nephropathy (IMN). We investigated the effectiveness of steroids in addition to treatment including RASB.